| Literature DB >> 34491000 |
Suzanne Chartier1, Lucile Boutaud1,2, Edouard Le Guillou3,4, Caroline Alby5, Clarisse Billon1,6, Anne-Elodie Millischer7, Catherine Caillaud3,4, Louise Galmiche8, Charlotte Mechler9, Pascale Sonigo7, Nathalie Boddaert7, Stanislas Lyonnet2, Sophie Rondeau5, Christine Bole-Feysot10, Cécile Masson11, Yves Ville2,12, Philippe Roth2,12, Isabelle Desguerre2,13, Férechté Encha-Razavi1, Tania Attie-Bitach1,2.
Abstract
BACKGROUND: Neuronal ceroid lipofuscinoses (NCLs) form a clinically and genetically heterogeneous group of inherited neurodegenerative disorders that share common neuropathological features. Although they are the first cause of neurodegenerative disorders in children, their congenital forms are rarely documented. They are classically due to mutations in the CTSD gene (the CLN10 disease). Affected newborns usually present severe microcephaly, seizures and respiratory failure leading to death within the first postnatal days or weeks. CASES: We report on two siblings, in which exome sequencing identified a novel homozygous CTSD variant. The first sib presented at birth with seizures, rapidly progressive postnatal microcephaly and visual deficiency related to retinal dysfunction. Progressive neurological deterioration leads to death at the age of 24 months. Cathepsin D activity was reduced in the cultured fibroblasts of this patient. The second sib, a fetus of 36 weeks of gestation, was delivered after pregnancy termination for brain abnormalities (in accordance with French Legislation) suggesting a recurrence of the disease. Fetal postmortem examination disclosed neuropathological features consistent with NCL.Entities:
Keywords: CLN10 disease; CTSD; cathepsin D; fetal pathology; lysosomal storage disorder; neuronal ceroid lipofuscinosis; prenatal diagnosis
Mesh:
Substances:
Year: 2021 PMID: 34491000 DOI: 10.1002/bdr2.1950
Source DB: PubMed Journal: Birth Defects Res Impact factor: 2.344